In IPF, low α2β1 integrin receptor concentrations lead to decreased PP2A levels, increased phosphorylated GSK-3β, and increased β-catenin and fibroblast proliferation. The gene discussed is PTPA; the disease is idiopathic pulmonary fibrosis.